- IMPAX Sued Based on ANDA for Generic Ultram(R) ER (Business Wire via Yahoo! Finance)
HAYWARD, Calif.----IMPAX Laboratories, Inc. today announced Purdue Pharma Products L.P. , Napp Pharmaceutical Group Ltd. , Biovail Laboratories International, SRL and Ortho-McNeil, Inc. have filed suit for patent infringement in the United States District Court for the District of Delaware based on the Company's submission of its Abbreviated New Drug Application for tramadol hydrochloride ...
- IMPAX sued for patent infringement on generic Ultram ER (News-Medical-Net)
IMPAX Laboratories, Inc. today announced Purdue Pharma Products L.P. ("Purdue"), Napp Pharmaceutical Group Ltd. ("Napp"), Biovail Laboratories International, SRL ("Biovail") and Ortho-McNeil, Inc. ("Ortho-McNeil") have filed suit for patent infringement in the United States District Court for the District of Delaware based on the Company's submission of its Abbreviated New Drug Application ...
- Biovail gets expanded use for Ralivia in Canada (AP via Yahoo! Finance)
Drugmaker Biovail said Monday that Canadian health regulators have expanded use of its pain medication Ralivia. The Canadian pharmaceutical firm said the once-a-day pill is now approved to treat "moderately severe" pain, in addition to moderate pain.
- Cipher reports second quarter fiscal 2008 results (CNW Group via Yahoo! Finance)
Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three and six months ended June 30, 2008.
- Biovail Reports Second-Quarter 2008 Financial Results (Business Wire via Yahoo! Finance)
TORONTO----Biovail Corporation today announced financial results for the three-month and six-month periods ended June 30, 2008. To the extent that this news release contains forward-looking statements, investors are cautioned that these are based on the Company's current views, and actual outcomes are not certain.
- Impax sued over generic painkiller (Contra Costa Times)
A unit of Johnson & Johnson, the world's largest maker of health-care products, sued generic drugmaker Impax Laboratories Inc. of Hayward, alleging infringement of a patent for the painkiller Ultram ER.
- Barr settles drug patent disputes (The Record)
MONTVALE - Barr Pharmaceuticals Inc., the generic-drug maker being bought by Teva Pharmaceutical Industries Ltd., and Boehringer Ingelheim GmbH agreed to settle patent disputes over Boehringer's Mirapex and Aggrenox drugs.
- Biovail Reports Second-Quarter 2008 Financial Results (Centre Daily Times)
Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced financial results for the three-month and six-month periods ended June 30, 2008. To the extent that this news release contains forward-looking statements, investors are cautioned that these are based on the Company's current views, and actual outcomes are not certain. For more information, see the note on forward-looking information ...